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SUMMARY
Dbf4-dependent kinases (DDKs) are required for
the initiation of DNA replication, their essential tar-
gets being the MCM2-7 proteins. We show that,
in Xenopus laevis egg extracts and human cells,
hyper-phosphorylation of DNA-bound Mcm4, but
not phosphorylation of Mcm2, correlates with DNA
replication. These phosphorylations are differentially
affected by the DDK inhibitors PHA-767491 and
XL413. We show that DDK-dependent MCM phos-
phorylation is reversed by protein phosphatase 1
(PP1) targeted to chromatin by Rif1. Loss of Rif1
increased MCM phosphorylation and the rate of
replication initiation and also compromised the abil-
ity of cells to block initiation when challenged with
replication inhibitors. We also provide evidence that
Rif1 canmediateMCMdephosphorylation at replica-
tion forks and that the stability of dephosphorylated
replisomes strongly depends on Chk1 activity. We
propose that both replication initiation and replisome
stability depend on MCM phosphorylation, which is
maintained by a balance of DDK-dependent phos-
phorylation and Rif1-mediated dephosphorylation.
INTRODUCTION
The ordered assembly of replication proteins onto chromatin is
highly regulated to ensure that DNA is precisely copied only
once each cell cycle. Beginning in late M/early G1 phase, double
hexamers of Mcm2–7 are loaded in excess onto replication
origins. In S phase, Dbf4-dependent Cdc7-kinase (DDK) and cy-
clin-dependent kinase (CDK) promote the conversion of Mcm2-7
into active Cdc45-MCMs-GINS (CMG) replicative helicases.
DDK is an essential and conserved serine/threonine kinase
that is formed of a Cdc7 catalytic subunit associated with its reg-
ulatory partner, Dbf4. In vertebrates, a second regulator of Cdc7,
Drf1, has been identified (Montagnoli et al., 2002; Yanow et al.,
2003; Takahashi and Walter, 2005; Yoshizawa-Sugata et al.,
2005). The key target of DDK for the initiation of DNA replication
is the Mcm2–7 complex. DDK phosphorylates the N terminus of
several Mcm2–7 subunits (minichromosome maintenance pro-
teins, or MCMs), specifically Mcm2, Mcm4, and Mcm6, (Lei
et al., 1997; Sato et al., 1997; Jiang et al., 1999; Masai et al.,
2000; Jares and Blow, 2000; Sheu and Stillman, 2010). Although
the contribution of each of these phosphorylation events to initi-
ation is not well understood, a key consequence of the hyper-
phosphorylation of Mcm4 is the relief of an inhibitory signal
that prevents replication (Sheu and Stillman, 2006, 2010). Signif-
icantly, cells lacking this Mcm4 N-terminal tail no longer require
DDK activity to complete replication. There is evidence that
Mcm2 phosphorylation by DDK is also required for DNA re-
plication (Hardy et al., 1997; Bruck and Kaplan, 2015). In
Xenopus laevis egg extracts, Mcm4 hyper-phosphorylation by
DDK occurs primarily on chromatin (Poh et al., 2014), though ex-
periments in mammalian cells have suggested that DDK phos-
phorylation of Mcm2 occurs primarily when it is not bound to
DNA (Montagnoli et al., 2006).
Recent studies have revealed that protein phosphatase 1
(PP1) restrains DDK activity by reversing the Cdc7-dependent
phosphorylation of Mcm4 (Poh et al., 2014; Hiraga et al., 2014;
Dave´ et al., 2014; Mattarocci et al., 2014). In Xenopus egg ex-
tracts, DDK executes its essential function early in S phase by
phosphorylating Mcm4 at all replication origins (Poh et al.,
2014). However, PP1 continually removes these Mcm4 phos-
phorylations so that when DDK activity is inhibited in the middle
of S phase, PP1 dephosphorylates MCMs at origins that have
not yet fired, and replication fails to finish. In addition, induction
of cell-cycle checkpoints resulted in increased PP1 recruitment
and subsequent Mcm4 dephosphorylation without altering
DDK activity (Poh et al., 2014).
In Saccharomyces cerevisiae and Schizosaccharomyces
pombe, PP1 is targeted to MCMs by Rap1-interacting factor
(Rif1) (Hiraga et al., 2014; Dave´ et al., 2014; Mattarocci et al.,
2014). Loss of this interaction leads to premature Mcm4 phos-
phorylation and misregulation of origin firing and allows cells to
compensate for reduced DDK activity. Loss of S. pombe or
mammalian Rif1 deregulates the replication timing program (Cor-
nacchia et al., 2012; Hayano et al., 2012; Yamazaki et al., 2012).
These findings are consistent with the hypothesis that Rif1 nega-
tively regulates DNA replication by recruiting PP1 to replication
origins to reverse DDK-dependent MCM phosphorylation.
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In this paper, we show that DDK-dependent hyper-phosphor-
ylation of Mcm4, but not phosphorylation of Mcm2, correlates
well with replication initiation in both Xenopus extracts and
human cells. We show that Rif1-directed PP1 opposes DDK-
dependent phosphorylation on MCMs, acting in parallel with
the ATR-dependent checkpoint pathway. In human cells, loss
of Rif1 results in accelerated progression through S phase due
to increased initiation, disrupting the normal replication timing
program. Loss of Rif1 can also alleviate the slow progression
through S phase that results when DDK is inhibited. Finally, we
provide evidence that Rif1-PP1 destabilizes replication forks
that have stalled in the absence of Chk1 activity.
RESULTS
DDK Differentially Phosphorylates MCM2–7 Subunits
The phosphorylation of Mcm2 on S40 and S53 has been ex-
ploited as a readout for Cdc7 kinase activity and has been
used in screens for the development of small-molecule inhibitors
of Cdc7 (Montagnoli et al., 2008; Koltun et al., 2012). We
used Xenopus egg extracts to evaluate the hyper-phosphoryla-
tion of Mcm4 and the phosphorylation of Mcm2 at the Xenopus
orthologous S40 and S53 residues (S25 and S38, respectively)
as readouts for the DDK activity required for DNA replication
(Figure 1A). As reported previously, DNA-bound Mcm4 was
hyper-phosphorylated by DDK (Poh et al., 2014). Treatment
with the DDK inhibitor PHA-767491 resulted in completely
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Figure 1. Phosphorylation of Different
MCM Subunits by Xenopus DDK Is
Reversed by PP1
(A–C) Xenopus egg extracts were supplemented
with demembranated sperm nuclei and optionally
supplemented with 50 mM PHA-767491 (PHA) or
100 mMXL413 (XL). (A) After incubation for 40 min,
isolated chromatin along with 0.5% (v/v) of the
supernatant was immunoblotted for Mcm4,
Mcm2-P-S40, Mcm2-P-S53, and total Mcm2. (B)
At the indicated times, chromatin was isolated
and immunoblotted for Mcm4, Mcm2-P-S40,
Mcm2-P-S53, total Mcm2, PCNA, and histone
H3. (C) Extract was supplemented with [a-32P]
dATP. Total DNA synthesis was determined at
indicated times.
(D and E) Sperm nuclei were incubated for 60 min
in Xenopus egg extracts treated with p27kip1 to
allow Mcm4 hyperphosphorylation. 50 mM PHA-
767491 or 100 mM XL413 plus or minus 1 mM
tautomycetin (Tauto) was then added, and chro-
matin was isolated either immediately after inhib-
itor addition (60 min) or later at every 5 for next
20 min (65–80 min). Chromatin samples were im-
munoblotted for Mcm4, Mcm2-P-S40, Mcm2-P-
S53, total Mcm2, and histone H3.
dephosphorylated Mcm4. Surprisingly,
the more specific and potent DDK inhibi-
tor XL413 (Hughes et al., 2012) caused
only inefficient inhibition (Figure 1A).
Phosphorylation of Mcm2 S53 behaved
similarly to Mcm4, appearing only on chromatin and being
reduced by DDK inhibition. In contrast, phosphorylation of S40
was strong in the chromatin fraction, as well as in the superna-
tant where it was insensitive to DDK inhibition.
To further investigate the effects of PHA-767491 and XL413 on
different MCM phosphorylation sites, we isolated chromatin at
short time intervals (Figure 1B) while monitoring DNA replication
(Figure 1C). PHA-767491 efficiently inhibited phosphorylation of
all assayedMCMs, including chromatin-boundMcm2 at S40. As
detailed previously (Poh et al., 2014), PHA-767491 also abol-
ished DNA replication (Figure 1C). In contrast, XL413 only de-
layed the hyper-phosphorylation of Mcm4, although it efficiently
inhibited Mcm2 phosphorylation on S40 and S53 (Figure 1B).
XL413 delayed progression through S phase but did not prevent
most of the DNA from being replicated. This shows that, among
the different DDK-dependent MCMs phosphorylations, Mcm4
phosphorylation provides a better functional correlation with
DNA replication than phosphorylation of Mcm2 on S40 or S53.
After DDK phosphorylates the Mcm2–7 complex, CDK activity
promotes the initiation of replication (Jares and Blow, 2000;
Walter, 2000). We used a CDK inhibitor, p27kip1, to prevent repli-
cation and, hence, stabilize phosphorylated MCMs on DNA. We
previously showed that, in these conditions, inhibition of DDK
activity leads to rapid dephosphorylation of Mcm4 by PP1 (Poh
et al., 2014). Inhibition of DDK with either PHA-767491 or
XL413 resulted in the loss of Mcm2 S40 and S53 phosphoryla-
tion, but only PHA-767491 caused efficient dephosphorylation
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of Mcm4 (Figures 1D and 1E). When tautomycetin, a specific in-
hibitor of PP1 (IC50 [half maximal inhibitory concentration] =
1.6 nM and 62 nM for PP1 and PP2, respectively), was added
along with PHA-767491 or XL413, virtually all MCMdephosphor-
ylation was abolished (Figure 1E). This suggests that PP1 activity
reverses DDK-dependent phosphorylation on all its MCM
substrates. This result also suggests that the inability of PHA-
767491 or XL413 to inhibit Mcm2 S40 phosphorylation in solu-
tion (Figure 1A) is due to the lack of PP1 activity, which, as we
have previously shown, is recruited to chromatin to promote
MCM dephosphorylation (Poh et al., 2014).
We next investigated the kinetics of DDK-dependent MCM
phosphorylation in HeLa cells by using mitotic shakeoff to
monitor cells as they move fromG1 to S and onto G2 (Figure 2A).
As has been previously reported (Masai et al., 2006), phosphor-
ylation of chromatin-bound Mcm4 (evidenced by slower
migrating bands on SDS-PAGE) occurred as cells entered into
and progressed through S phase (Figure 2B). Consistent with re-
sults from Xenopus, Mcm4 in the HeLa soluble fraction behaved
differently and was typically seen as one strong, fast migrating
band and one slower migrating weak band that did not vary
over the cell cycle. Phosphorylation of Mcm2 S40 was most
evident in the soluble fraction rather than on chromatin. More-
over, the phosphorylation of soluble Mcm2 S40 was strongest
in G1, it nearly disappeared during S phase, and it returned as
cells moved into G2 phase.
The efficacy of both PHA-767491 and XL413 has been as-
sessed by their ability to inhibit Cdc7-dependent phosphoryla-
tion of soluble Mcm2 in human tissue culture cells (Montagnoli
et al., 2008; Koltun et al., 2012). To our knowledge, neither was
assessed for Mcm4 phosphorylation status. To test this, HeLa
cells were replated after a mitotic shakeoff and then challenged
with PHA-767491 or XL413. Each compound inhibited DNA
replication and S-phase entry, with PHA-767491 displaying
stronger activity (Figure 2C). The stronger effect of PHA-
767491 is likely explained by its promiscuous activity against
other kinases, including Cdk9, which is required for S-phase en-
try (Montagnoli et al., 2008; Hughes et al., 2012). PHA-767491
induced apoptosis in HeLa cells as cells enter S phase after
mitotic shakeoff (Figure S1A). However, when the inhibitors
were added just after the start of S phase, PHA-767491 no longer
had a strong apoptotic effect, and both PHA-767491 and XL413
appeared to inhibit S-phase entry to a similar degree (Figures
S1B and S1C). PHA-767491 or XL413 also suppressed phos-
phorylation of chromatin-bound Mcm4, as well as S40 and S53
of Mcm2, consistent with these being direct DDK targets (Fig-
ure 2D). Congruent with results in Xenopus egg extracts, inhibi-
tion of PP1 with tautomycetin resulted in the accumulation of
phosphorylated, chromatin-bound Mcm2 and Mcm4. Tautomy-
cetin also reduced the dephosphorylation of chromatin-bound
MCMs induced by XL413 or PHA-767491. In contrast to the
experiments in egg extracts, both inhibitors reduced phosphor-
ylation of soluble Mcm2, suggesting more active dephosphory-
lation of soluble Mcm2 in human cells. Both XL413 and PHA-
767491 consistently increased the proportion of cells that
remained in the near-2N population (Figure S1C) when added
to cells synchronized in S phase; co-addition of tautomycetin
partially reversed this effect. These results show that, in both
Xenopus egg extracts and human cells, phosphorylation of
Mcm4, but not Mcm2, provides the best indicator of DDK activity
required for DNA replication initiation and that phosphorylation
of chromatin-boundMCMsbyDDK is counteracted by phospha-
tase activity of PP1.
PP1 Requires Rif1 to Dephosphorylate the Mcm2–7
Complex
Previous data in yeast has established that Rif1 recruits PP1
to replication origins to dephosphorylate MCMs (Dave´ et al.,
2014; Hiraga et al., 2014; Mattarocci et al., 2014). The
motifs on Rif1 required for interaction with PP1 are conserved
in Xenopus andmammalian Rif1 homologs but are located within
the C terminus of the protein (Sreesankar et al., 2012). In order to
test whether Rif1 directs PP1 to replication origins in vertebrates,
we raised an antibody to XenopusRif1 (Figure S2A). Immunopre-
cipitation of Rif1 from Xenopus egg extracts co-precipitated
PP1g and PP1b (Figure 3A). Moreover, PP1b was detected by
mass spectrometry in immunoprecipitates of Rif1 from chro-
matin (Figure S3A). Inhibition of Xenopus Cdc7 did not obviously
reduce the Rif1-PP1 interaction (Figure S3B) as observed in
yeast (Hiraga et al., 2014). In human tissue culture cells PP1a
and PP1g, Mcm2 and Cdc7 were co-precipitated with chro-
matin-bound Rif1 (Figure 3B).
If Rif1 targets PP1 to DNA-boundMcm2-7, then depleting Rif1
from Xenopus egg extracts should mimic the effect of inhibiting
PP1. Depletion of >90% of Rif1 from Xenopus egg extracts (Fig-
ure S3C) substantially decreased the amount of PP1 on chro-
matin and reduced the rate of dephosphorylation of Mcm4 and
Mcm2 that occurred after DDK inhibition (Figures 3C and S3D).
A more robust Rif1 depletion (>95%) caused even greater loss
of chromatin bound Rif1 and PP1g with a corresponding in-
crease in Mcm4 phosphorylation (Figures S3E and S3F). The
process of immunodepletion slightly compromises Cdc7 nuclear
import (Poh et al., 2014), reducing Mcm4 hyper-phosphorylation
(Figures 3C, S3D, and S3F) and sensitizing DNA replication to
further DDK inhibition (Figure S4A).
We performed parallel experiments in asynchronous HeLa
cells using small interfering (si)RNA against Rif1. Hyper-phos-
phorylated Mcm4 accumulated in proportion to the amount of
Rif1 knocked down by RNAi treatment (Figure 3D). The accumu-
lation of hyper-phosphorylated Mcm4 was more pronounced in
cells synchronized in S phase following a mitotic shakeoff (Fig-
ure 3E). As we observed in Xenopus (Figure 3C), knockdown of
Rif1 in human cells rendered phosphorylation of Mcm4 relatively
insensitive to DDK inhibition (Figure 3E). These data clearly show
that, in both Xenopus and human systems, loss of Rif1 increases
DDK-dependent phosphorylation of MCMs in a manner that is
similar to inhibition of PP1 and implicates Rif1 in directing PP1
to origins of replication.
Rif1 Is Essential for Regulating S-phase Progression
We next investigated the potential role of Rif1 in regulating pro-
gression into and through S phase. When Xenopus extracts
were immunodepleted of Rif1, the rate of replication increased
compared to control immunoglobulin-G (IgG)-depleted extract
(Figures 4A and S4B). Furthermore, Rif1 depletion reduced the
inhibitory effect of PHA-767491 on DNA replication (Figure 4B).
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Figure 2. Human Mcm4 Phosphorylation Predicts DNA Replication
(A and B) HeLa cells were synchronized in early M phase by mitotic shakeoff and then replated for different times. (A) DNA content of cells as determined by flow
cytometry. (B) Immunoblot of Mcm4, total Mcm2, and Mcm2-P-S40 on and off chromatin. Lamin B and tubulin serve as loading and fractionation controls.
(C) Cells were synchronized as in (A) and were replated with 10 mMPHA-767491 or 10 mMXL413 in the media. At 7.5 hr, cells were pulsed for 30min with EdU and
then analyzed by flow cytometry for DNA content and EdU incorporation. An example plot and gate are shown plus the mean and SD of EdU+ cells from three
experiments.
(D) Cells were synchronized as in (A) and replated for 8 hr (t-2); media was then optionally supplemented with 10 mMPHA-767491 (PHA), 10 mMXL413 or 225 nM
tautomycetin (Tauto) as indicated for 2 hr. Cells were then immunoblotted for Mcm4, Mcm2-P-S40, Mcm2-P-S53, or total Mcm2 on and off chromatin. Lamin B
and tubulin served as loading and fractionation controls.
See also Figure S1.
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These results show that, in Xenopus egg extracts, Rif1 counter-
acts the function of DDK in driving S-phase progression.
A similar effect was seen when Rif1 levels were reduced in hu-
man cells using RNAi. On release from a double thymidine block,
siRif1 HeLa cells moved more quickly through S phase and
incorporated 5-ethynyl-20-deoxyuridine (EdU) at a higher rate
than control cells (Figures 4C–4E). Moreover, the inhibition of
S-phase progression observed with XL413 treatment was
greatly decreased in siRif1 cells. This is consistent with the
idea that cells move through S phase at an enhanced rate
when DDK activity is not restrained by Rif1-PP1.
The enhanced rate of S phase progression observed in cells
deficient for Rif1 could, in principle, be due to increased replica-
tion initiation and/or faster replication fork movement. To test
this, we assessed progression through the replication timing pro-
gram by observing the spatial pattern of DNA synthesis in cells
released from a double thymidine block (O’Keefe et al., 1992;
Gillespie and Blow, 2010). Figure 5A shows that EdU incorpora-
tion in Rif1-depleted cells was abnormal, both in its intensity
and in showing less discrete labeling patterns. Incorporation of
EdU 90 min after release from a thymidine block was greater in
the siRif1 cells in comparison to the siCtrl cells (Figure 5B), in
agreement with their faster progression through S phase (Fig-
ure 4E). The number of replication foci per nucleus was slightly
lower in the siRif1-treated cells (Figure 5C), though the intensity
of the observed EdU foci nearly doubled (Figure 5D). This could
represent the activation of more replication domains that partially
overlap with one another, leading to an apparent decrease in the
number of foci. At later time points after thymidine release, there
were no major differences between siCtrl and siRif1-treated cells
(Figure S5), implying that aberrant EdU incorporation due to the
absence of Rif1 occurs primarily in early S phase.
DNA fiber analysis showed that the replication fork speed was
similar in siCtrl and siRif1-treated cells (Figure 5E). Previous work
in mammalian cells has shown that loss of Rif1 results in limited
change in inter-origin distances (Cornacchia et al., 2012) and a
highly disrupted chromatin structure (Foti et al., 2016). Therefore,
the increased levels of EdU incorporation we observed after Rif1
depletion likely reflects initiation occurring across larger timing
domains at an otherwise unchanged origin density, consistent
with an underlying change in chromatin structure.
Rif1 Regulates S-phase Progression in Parallel with
ATR/Chk1
Previous work has implicated Rif1 in the regulation of replication
initiation in response to activation of cell-cycle checkpoints (Ku-
mar and Cheok, 2014; Renard-Guillet et al., 2014). Therefore, we
sought to understand whether Rif1 was regulated by the S-phase
checkpoint kinases ATM and ATR. We observed S phase-pro-
gression of synchronized HeLa cells after treatment with an ATM
inhibitor (KU55933), a Chk1 inhibitor (CHIR-124), or a generic in-
hibitor of ATM/ATR/DNA-PK (caffeine) in the presence and
absence of Rif1 (Figure 6). Both caffeine and CHIR-124, but not
KU55933, inhibited S-phase progression in siCtrl cells, consistent
with the known role of ATR and Chk1 in promoting fork stability
(Smits and Gillespie, 2015). siRif1 cells treated with caffeine or
CHIR-124 showed an increase in EdU incorporation and S-phase
progression (Figure 6A). This implies that Rif1 has a negative
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Figure 3. Rif1 Targets PP1 to MCMs at
Replication Origins
(A and B) Rif1 was immunoprecipitated from
Xenopus egg extract (A) or HeLa cell nuclear
extracts (B) using antibodies against Rif1 or
with pre-immune rabbit IgG and samples were
immunoblotted for Rif1, PP1g, PP1b, PP1a, Mcm2
or Cdc7 as indicated.
(C) Sperm nuclei were incubated for 60 min in Xen-
opus extracts immunodepleted using antibodies
against Rif1 (DRif1) or control pre-immune rabbit
IgGs (DIgG). Sperm nuclei and p27kip1 were added
to extracts to allow Mcm4 hyper-phosphorylation.
Chromatin was isolated at 60 and 75 min post-in-
cubation. Optionally, after 60min of incubation with
DNA, 50 mM PHA-767491 (PHA) was added, and
chromatin was isolated at indicated times over the
next 25 min (65–85 min). Chromatin samples were
immunoblotted for Mcm4,Mcm2-P-S40, Mcm2-P-
S53, Mcm7, Rif1, and PP1g.
(D) HeLa cells were transfected with increasing
amounts of siRNA targeting Rif1 and tested for
knockdown efficiency as well as Mcm4 phos-
phorylation at 24 and 48 hr after transfection.
Mcm5 served as a loading control (Ctrl).
(E) 48 hr after transfection with Rif1 or control
RNAi, HeLa cells were synchronized in S phase by
mitotic shakeoff and treated for 30 min with either
10 mM PHA-767491 (PHA) or 10 mM XL413 (XL).
Chromatin-bound Mcm4 was analyzed by immu-
noblotting,withMcm5 serving as a loading control.
See also Figure S2.
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regulatory effect on S-phase progression that is independent of
ATR and Chk1. To determine whether this Rif1 function occurs
by opposing DDK activity, we observed S-phase progression in
synchronized cells treated with a DDK inhibitor, a Chk1 inhibitor,
or both in the presence and absence of Rif1. In control cells,
both CHIR-124 and XL413 individually caused a slight reduction
in EdU incorporation, which was enhanced when combined with
each other (Figure 6B). In contrast, XL413 had no significant effect
on EdU incorporation or S-phase progression in siRif1 cells, either
aloneorwhencombinedwithCHIR-124.Thisstrongly implies that,
in the absence of exogenously applied replicative stresses, Rif1
restricts S-phase progression by opposing DDK function in a
manner that is independent of ATR and Chk1.
We next investigated Rif1 function under conditions of replica-
tion stress. It has previously been shown in Xenopus egg ex-
tracts that the topoisomerase II inhibitor etoposide inhibits
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Figure 4. Rif1/PP1 Activity Is Required
to Oppose Cdc7 Activity for Normal
Replication
(A and B) Control (DIgG) and Rif1 (DRif1)-depleted
Xenopus extracts were incubated with de-
membranated sperm nuclei and [a-32P]dATP. (B)
Extracts were optionally supplemented with
increasing concentrations of PHA-767491 (PHA)
(0.75–6 mM). The reactions were stopped at the
indicated times (A) or at 150 min (B), and total DNA
synthesis was determined.
(C and D) Flow cytometry was used to analyze
cellular DNA content in the following experiment:
HeLa cells were transfected with control or Rif1
siRNA, synchronized by a double thymidine block,
and released into untreated (C) or XL413-treated
(D) media for the indicated times.
(E) Cells from the 6-hr time points from (C) and
(D) were pulsed with EdU and analyzed by flow
cytometry.
See also Figure S4.
DDK activity via both checkpoint-depen-
dent and checkpoint-independent path-
ways (Costanzo et al., 2003; Poh et al.,
2014). Therefore, we added etoposide to
control and Rif1-depleted HeLa cells syn-
chronized in early S phase. As expected,
this caused a reduction in EdU incorpora-
tion and S phase progression (Figure 6C).
When treated with both etoposide and
CHIR-124, control cells had great diffi-
culty proceeding with S phase, and
incorporation of EdU was significantly
decreased. This is consistent with the
known role of Chk1 in stabilizing stalled
replication forks, as confirmed by DNA
fiber analysis, which showed a decrease
in the average labeled track length of
50% (Figure 6D). Remarkably, in Rif1-
deficient cells, co-treatment of etoposide
and CHIR-124 resulted in near-normal
replication profiles as judged by fluores-
cence-activated cell sorting (FACS). DNA fiber analysis showed
that, in Rif1-deficient cells, the length of labeled tracks was
largely unaffected by etoposide or CHIR-124. These data are
consistent with the idea that, in addition to its role in regulating
initiation, Rif1 destabilizes replication forks that have stalled in
the absence of Chk1 activity.
PP1-Dependent Dephosphorylation of CMG
Destabilizes Replication Forks
The results presented earlier show that Rif1-PP1 reverses
DDK-dependent phosphorylation of chromatin-bound MCMs.
However, at any given moment, only a fraction of the total
chromatin-bound MCMs are active as replicative CMG heli-
cases. Therefore, we analyzed the effect of Rif1-PP1 on CMG
complexes using Xenopus egg extracts. DNA was incubated
for 60 min in extract containing 100 mM aphidicolin (to inhibit
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replication fork progression) and 5 mM caffeine (to allow dor-
mant origins to fire, thereby increasing the number of active
CMGs) (Woodward et al., 2006). PHA-767491 and/or tautomyce-
tin were then added, after which CMG complexes were isolated
by immunoprecipitation of Cdc45 (Figure 7A). DDK inhibition
caused significant dephosphorylation of total chromatin-bound
MCM4 but only partial dephosphorylation of MCM4 in the
CMGs. In both cases, dephosphorylation was inhibited by tauto-
mycetin. However, there was strong PP1-dependent dephos-
phorylation of MCM2 S40, both on total chromatin-bound
MCM2 and in the CMGs. MCM2 S53 phosphorylation was not
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Figure 5. Rif1 Restrains Replication Ini-
tiation
(A–D) HeLa cells were treated with control or Rif1
siRNA, synchronized by double thymidine block,
and then released. (A) At the indicated periods after
release, cells were pulsed with EdU for 30 min. The
spatial patterns of DNA synthesis were examined
by fluorescence microscopy. (B–D) 90 min after
release, the total EdU intensity of the nucleus (B),
the number of replication foci per nucleus (C), and
the intensity of the EdU foci (D) were quantified (25
nuclei per condition).
(E) Cells were labeled for 20 min with CldU 70 min
after release from thymidine (Thy), washed, and
pulsed briefly with IdU (10 min). DNA fibers were
spread, and the length of 100 CldU-labeled tracks
was measured. Data were evaluated for signifi-
cance using an unpaired, two-tailed t test.
See also Figure S5.
significantly affected by DDK inhibition.
These results suggest that PP1-depen-
dent MCM dephosphorylation occurs on
the CMG, but with different kinetics at
different MCM sites compared to MCM
complexes at licensed origins.
Previouswork has shown that, unlike the
case in mammalian cells, replisomes in
Xenopus extracts are not destabilized
when Chk1 is inhibited (Luciani et al.,
2004). Sinceour results in humancells indi-
cate that replisome stability involves both
MCM phosphorylation and Chk1 activity
(Figure 6D), we considered whether the
very high degree of DDK-mediated MCM
phosphorylation in Xenopus egg extracts
(Figure 1) helps stabilize replisomes, even
whenChk1 is inhibited.To test this, replica-
tion forks in Xenopus egg extracts were
stalled with aphidicolin, new initiation
events were blocked with p27kip1, and the
incubation was continued in the presence
of PHA-767491 plus or minus caffeine
(which, by inhibiting ATR, prevents Chk1
activation). Chromatin was then isolated,
and replication fork elongation was
measured in a run-on assay (Figure 7B).
When caffeine was added in addition to PHA-767491, the overall
rate of replicationwas reduced to 76%± 5% (mean ± SEM, six in-
dependent experiments; p < 0.05, an unpaired, two-tailed t test).
The results of the experiments shown in Figures 7A and 7B are
consistent with the data from HeLa cells in Figure 6D, and they
suggest that, in the absence of ATR/Chk1 activity, DDK-depen-
dent phosphorylation of CMG complexes becomes important to
maintain replisome stability.
Finally, we investigated Rif1’s ability to inhibit S-phase pro-
gression in response to a range of different replication stresses.
To this end, we observed EdU incorporation in the presence and
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Figure 6. Rif1 Regulates S-phase Progres-
sion and Replisome Stability in Parallel
with ATR/Chk1
(A–C) HeLa cells were treated with control or Rif1
siRNA, synchronized and released from a double
thymidine block for 2 hr, and then optionally
treated for 2 hr with caffeine (5 mM), CHIR-124,
KU55933, XL413, or etoposide as indicated. EdU
was added in the last 30 min of treatment and the
cells were analyzed by flow cytometry.
(D) HeLa cells were treated with control or Rif1
siRNA, synchronized and released from a double
thymidine (Thy) block for 70min, labeled with CldU
for 20min, washed, and subsequently labeled with
IdU while being incubated with CHIR-124 (CHIR),
etoposide (ETO), or both for 1 hr. DNA fibers were
prepared, and the IdU length of 100 tracks were
counted per experimental condition. Data were
evaluated for significance using an unpaired, two-
tailed t test, with significant differences in fiber
length between siCtrl untreated and siCtrl ETO +
CHIR (p < 0.0001), and between siCtrl untreated
and siRif1 untreated (p = 0.0321). There was no
significant difference found between any siRif1
treatments.
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absence of Rif1 in HeLa cells exposed to a variety of drugs: 5mM
hydroxyurea, 1 mg/mL aphidicolin, 0.02% methyl methanesulfo-
nate, 5 mM camptothecin, and 5 mM etoposide (or 45 J/m2 UV
light) (Figures 7C and S6). In each case, control cells responded
by reducing the rate of S-phase entry and decreasing the popu-
lation of cells incorporating EdU. However, in Rif1 knockdown
cells, the response to all these inhibitors was diminished, leading
to a decrease in the near-2N population and a corresponding in-
crease in cells incorporating EdU.
DISCUSSION
We show here how the interplay between DDK-dependent
phosphorylation and Rif1-PP1-dependent dephosphorylation
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Xenopus Xenopus Figure 7. Rif1-PP1 Regulates Replisome
Stability and S-phase Progression
(A) Sperm nuclei were incubated for 60 min in
Xenopus egg extracts supplemented with 100 mM
aphidicolin and 5mMcaffeine. 50 mMPHA-767491
(PHA) ± 1 mM tautomycetin (Tauto) was added
for a further 25 min. Chromatin-bound proteins
were immunoprecipitated with antibodies against
Cdc45 or pre-immune sheep IgG. Samples were
immunoblotted for Cdc45, Mcm4, Mcm2-P-S40,
Mcm2-P-S53, total Mcm2, and Psf2.
(B) Xenopus egg extracts were supplemented
with demembranated sperm nuclei and 100 mM
aphidicolin. After 60 min, p27kip1 was added and
aliquots were supplemented with 50 mM PHA-
767491 ± 5 mM caffeine (CAFF). After a further
25 min, chromatin was transferred to extract sup-
plemented with [a-32P]dATP, p27kip1 and 50 mM
PHA-767491 ± 5 mM caffeine to match the first
incubation. At the indicated times, incorporation of
[a-32P]dATP into nascent DNA was determined
and expressed as normalized values against the
incorporation at 1 min.
(C) HeLa cells were treated with control or Rif1
siRNA, synchronized by double thymidine block,
and released 2 hr before either treatment with hy-
droxyurea (HU; 5 mM), aphidicolin (APH; 1 mg/mL),
methyl methanesulfonate (MMS; 0.02%), camp-
tothecin (CPT; 5 mM), etoposide (ETO; 5 mM), or UV
(45 J/m2). EdU was added in the last 30 min of
treatment, and 2 hr after the start of the treatments,
cells were harvested, fixed, and analyzed by flow
cytometry.
(D) Model for the role of Rif1 and Cdc7 in control-
ling replication initiation and replisome stability.
Replication initiation is regulated by the phos-
phorylation of Mcm2-7 by Cdc7, opposed by Rif1/
PP1. Active replisomes are also dephosphorylated
by Rif1/PP1, which requires ATR/Chk1 to stabilize
them in response to replicative stresses.
See also Figure S6.
of MCM proteins regulates S-phase
progression and replisome stability.
DDK-dependent hyper-phosphorylation
of Mcm4, but not Mcm2, correlates well
with replication initiation in both Xenopus
and humans. Rif1-directed PP1 dephosphorylates DDK-depen-
dent phosphorylation on all MCMs. Loss of Rif1 accelerates pro-
gression through the S phase due to increased initiation, disrupt-
ing the normal replication timing program independently of the
ATR-dependent checkpoint pathway. We also show that Rif1
is required to destabilize replication forks that have stalled in
the absence of ATR-Chk1 activity.
MCM4 Phosphorylation Correlates with Replication
Initiation
We have shown that DDK-dependent phosphorylation sites on
different MCMs are differentially regulated, with slight variations
between Xenopus and human systems. Mcm4 hyper-phos-
phorylation, but not MCM2 phosphorylation, at S40 and S53
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correlates well with replication initiation. This is in agreement
with studies in yeast where phosphorylation of the N terminus
ofMcm4 is required to relieve an inhibitory function on replication
initiation (Sheu and Stillman, 2010).
Unexpectedly, we found that XL413 is a poor inhibitor of repli-
cation in comparison to PHA-767491 in Xenopus egg extracts.
This could be explained by XL413’s poor inhibition of DDK activ-
ity on Mcm4. In vitro, XL413 is much more specific and has more
extensive van der Waals interactions within Cdc7’s active site
than PHA-767491 (Hughes et al., 2012). However, extended
XL413 treatment in HeLa cells seems to merely delay progres-
sion through S phase rather than completely shut down replica-
tion. This perhaps provides a mechanistic explanation for why
XL413 fails to induce apoptosis efficiently in cancer cells (Sasi
et al., 2014). It is also important to note that several drug screens
have been carried out using Mcm2 S40 phosphorylation as a
marker of DDK activity. This phosphorylation can be observed
off chromatin and outside of S phase, and it is possible that there
is a structurally different form of DDK that phosphorylates MCMs
off chromatin.
Rif1 Controls S-phase Progression and Replisome
Stability
We have established that vertebrate Rif1 interacts with PP1.
We show that, consistent with data from yeast (Dave´ et al.,
2014; Hiraga et al., 2014; Mattarocci et al., 2014), Rif1 promotes
the PP1-mediated dephosphorylation of MCMs, both in humans
and Xenopus. We show that, in both these systems, one of Rif1’s
functions is to restrain replication initiation by reversing DDK-
mediated phosphorylation of MCMs. Previous work has shown
that loss of Rif 1 leads to an aberrant replication timing pheno-
type of Rif1-deficient cells (Cornacchia et al., 2012; Hayano
et al., 2012; Yamazaki et al., 2012; Foti et al., 2016). Our data
are consistent with the idea that loss of the phosphatase causes
premature Mcm4 hyper-phosphorylation, thus causing pro-
miscuous activation of replication origins and disruption of the
timing program (Figure 7D, top). This function of Rif1 can occur
concomitantly with its proposed role in organizing 3D chromatin
structure, which was recently shown to affect replication timing
and 3D nuclear organization in mouse cells (Foti et al., 2016).
This altered 3D chromatin structure may cause improper regula-
tion of MCM phosphorylation.
Significantly, combining the loss of Rif1 with inhibition of ATR/
Chk1 enhances the already increased rate of EdU incorporation
and progression through S phase seen in cells deficient in Rif1
alone. This is consistent with the idea that DDK/Rif1 and ATR/
Chk1 provide distinct restraints on replication initiation, with
DDK/Rif1 regulating MCM phosphorylation and ATR/Chk1 regu-
lating CDK activity.
We also show that there is a PP1-dependent dephosphoryla-
tion of MCMs in active CMG helicases, with a different spec-
trum of MCM dephosphorylation than that seen on unfired
MCM2-7 hexamers. When replication fork progression is in-
hibited, ATR/Chk1 becomes essential to prevent irreversible
fork stalling (Smits and Gillespie, 2015; Sørensen et al., 2005).
Our data suggest that the fork stability function of ATR/Chk1 is
critical because of the action of Rif1. In Xenopus, extract replica-
tion forks, which are normally relatively insensitive to ATR/Chk1
inhibition (Luciani et al., 2004), become unstable when combined
with DDK inhibition. In HeLa cells, inhibition of Rif1-PP1 prevents
the inactivation of replication forks that occurs when the ATR/
Chk1 pathway is inhibited. The simplest explanation for this
fork stability function of Rif1 is that it is associated with Rif1’s
ability to drive MCM dephosphorylation, though it is also
possible that replisome stability depends on the phosphorylation
of other replisome proteins.
In this model (Figure 7D, bottom), DDK-dependent MCM
phosphorylation of the active CMG helicase helps maintain it in
an active conformation. Only once dephosphorylated by Rif1-
PP1 does the replisome become susceptible to destabilization,
and then the fork stability function of ATR/Chk1 becomes partic-
ularly important. This second role of Rif1 has interesting implica-
tions for the use of DDK inhibitors as anti-cancer agents. Since
replisome stalling is likely to be particularly difficult to reverse,
combining replication stresses with DDK inhibitors is likely to
prove significantly more toxic to cancer cells lacking proper
checkpoint controls.
EXPERIMENTAL PROCEDURES
Xenopus Egg Extract and DNA Templates
Metaphase-arrested Xenopus laevis egg extract and demembranated
Xenopus sperm nuclei were prepared and used as described previously
(Gillespie et al., 2016). Briefly, extracts were released into interphase from
metaphase arrest once incubated with 0.3 mM CaCl2 for 15 min at 23
C. For
DNA synthesis reactions, sperm nuclei were incubated at 3–10 ng DNA/mL in
extract. DNA synthesis was assayed by measuring incorporation of [a-32P]
dATP into acid-insoluble material followed by scintillation counting (Gillespie
et al., 2016).
Chromatin Isolation from Egg Extract
Chromatin isolation from egg extract was carried out as described previously
(Gillespie et al., 2012). Briefly, extract was diluted with ice-cold nuclear isola-
tion buffer (NIB) (50 mM KCl, 50 mM HEPES-KOH [pH 7.6], 5 mM MgCl2,
0.5 mM spermidine, 0.15 mM spermine, and 2 mM DTT) containing phospha-
tase inhibitors, under-laid with 20% sucrose (w/v) in NIB, and centrifuged in a
swinging-bucket rotor at 2,1003 g for 5 min at 4C. Following a cushion wash,
chromatin was spun down at 13,000 3 g for 2 min in a fixed-angle rotor. The
resulting pellet was resuspended in SDS loading buffer.
To isolate intact nuclei for transfer experiments, Triton X-100 was omitted
from all buffers. Extracts were diluted as before, under-laid with a double
cushion of NIB + 20% sucrose and NIB + 30% glycerol (v:v in NIB), and centri-
fuged in a swinging bucket rotor. Following a cushion wash, nuclei were resus-
pended in the glycerol cushion and added to the second extract at a final DNA
concentration of 10 ng/mL.
Cell Culture and Synchronization
HeLa cells were obtained from the American Type Culture Collection (ATCC)
and maintained in DMEM (Invitrogen) supplemented with 10% fetal bovine
serum (FBS; Invitrogen) and antibiotics at 37C in 5% CO2. For mitotic shake-
off experiments, HeLa cells were synchronized in early S phase via double
thymidine block, washed with PBS, and released into media for 6 hr before
treatment with nocodazole at 100 ng/mL for 4 hr. Flasks were knocked onto
the benchtop to release mitotic cells and then were washed with pre-warmed
PBS and replated.
Protein Preparation and Isolation of Chromatin Proteins in Human
Cells
Whole-cell extracts were obtained from HeLa cells by extraction in RIPA buffer
(50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1% IGEPAL CA-630, 0.5% sodium
deoxycholate, 1 mM EDTA, 1 mM PMSF, 1 mM sodium orthovanadate,
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PhosSTOP (04906845001, Roche). For chromatin fractionation, cells were har-
vested from plates, washed with PBS, and resuspended in cytoskeleton (CSK)
buffer (10 mM HEPES [pH 7.4]; 300 mM sucrose; 100 mM NaCl; 3 mMMgCl2;
0.5% Triton X-100; 1 mM PMSF; 0.1 mM sodium orthovanadate; PhosSTOP
[04906845001, Roche]; and 1 mg/mL each of leupeptin, aprotinin, and pepsta-
tin) for 15 min on ice. Tubes were centrifuged at 5,0003 g for 5 min at 4C, and
the non-chromatin bound supernatant was frozen in liquid nitrogen. The chro-
matin pellet was washed twice using CSK buffer without Triton X-100, centri-
fuged at 5,000 3 g for 5 min at 4C, and frozen in liquid nitrogen. Protein was
prepared from chromatin pellets by extraction in RIPA buffer.
FACS Analysis
At 30min before collecting cell samples, EdUwas added to cells (final concen-
tration, 40 mM), after which cells were harvested and fixed with ice-cold 70%
ethanol. EdU detection was achieved using the Click-IT Plus EdU Alexa Fluor
647 Flow Cytometry Assay Kit (C10635, Life Technologies), and DNA content
was measured with propidium iodine. EdU incorporation and DNA content
were measured using BD FACSCanto, and data were analyzed using the
FlowJo program.
Immunoblotting
For immunoblotting, samples were separated on either 3%–8% Tris-acetate
or 4%–12% Bis-Tris gradient gels (Invitrogen). Proteins were transferred
onto PVDF (GE Healthcare, RPN303F) or nitrocellulose membranes (GE
Healthcare, 10600001) using a wet transfer system, blocked in PBS with
0.2% Tween-20 and 5% non-fat milk. After incubation with primary and sec-
ondary antibodies, either membranes were developed using enhanced chem-
iluminescence detection (SuperSignal West Pico Chemiluminescent; Thermo
Scientific, 34087), or signals were acquired using Odyssey bio-systems (LI-
COR Biosciences) where LI-COR secondary antibodies were used.
Immunodepletion and Immunoprecipitation
To deplete Rif1 from Xenopus egg extract, metaphase-arrested extract was
activated to release it into interphase, and subsequently, 1 vol of extract
was incubated twice with 0.6 vol of protein A agarose beads conjugated to
anti-Rif1 antibody for 45 min at 4C.
To precipitate Rif1 from Xenopus egg extract, metaphase-arrested extract
was released into interphase and then diluted 5-fold in LFB (licensing factor
buffer) 1/50 (40 mM HEPES-KOH [pH 8.0]; 20 mM K2H(PO4)/KH2(PO4) [pH
8.0]; 2 mM MgCl2; 1 mM EGTA; 2 mM DTT; 10% [w/v] sucrose; 1 mg/mL
each of leupeptin, pepstatin, and aprotinin; supplemented with 50 mM KCl).
The diluted extract was incubated for 1 hr at 4Cwith protein A agarose beads
covalently conjugated to anti-Rif1 antibody with bis(sulfosuccinimidyl)suber-
ate (21580, ThermoFisher Scientific). The beads were then washed five times
with filtered PBS before resuspension in loading buffer. Cdc45 was immuno-
precipitated according to Gambus et al. (2011), with modifications. Briefly,
chromatin samples were isolated in 10 vol of ice-cold NIB containing
100 mM KCl and were underlaid with NIB buffer containing 30% sucrose
and spun for 10 min at 2,500 3 g at 4C. PHA-767491 or tautomycetin were
added optionally to the buffers. Proteins were released after DNA digestion
with 2 U/mL Benzonase for 10 min at room temperature. After resuspension,
KCl was adjusted to 100 mM, and chromatin was incubated for 5 min at
room temperature before the final spin. Cdc45 antibody was covalently
conjugated to Dynabeads Protein G (10003D, Thermo Fisher Scientific) with
bis(sulfosuccinimidyl)suberate for 2 hr at 4C.
Chromatin-bound Rif1 was immunoprecipitated fromHeLa cells according to
a procedure modified from Foti et al. (2016). HeLa cells were washed twice in
ice-cold PBS before adding 5 mM bis(sulfosuccinimidyl)suberate to cross-link
surfaceproteinandwere incubatedon ice for30min.The reactionwasquenched
with 20mM Tris-HCl (pH 7.5) for 15min. Cells were washed twice with PBS and
lysed in hypotonic buffer (25 mM Tris [pH 7.4], 2 mM MgCl2, 50 mM KCl, and
1 mM EDTA) plus protease inhibitor cocktail (Roche) on ice for 20 min.
Nuclei were washed twice in hypotonic buffer and then resuspended in RIPA
buffer plus inhibitor cocktail and incubated at room temperature for 30 min
with 50 U/mL benzonase. After clarification by centrifugation, lysates were
subjected to co-immunoprecipitation (co-IP) using anti-Rif1 antibody cova-
lently conjugated to Dynabeads Protein A (10008D, Thermo Fisher Scientific)
with bis(sulfosuccinimidyl)suberate for 1 hr at 4C. Beads were then washed
(five times) with filtered PBS before resuspension in SDS loading buffer.
RNAi and Transfections
The following siRNA duplexes were used: siCtrl 50-UAGCGACUAAACACAU
CAA-30 (#D0012100120, Fisher Scientific) and siRif1 (sc-62944, Santa Cruz
Biotechnology). Cells were transfected using RNAiMax (#13778150, Invitro-
gen). Briefly, siRNA was mixed with Lipofectamine in Opti-MEM medium
(#31985070, Invitrogen) and added to 50% confluent cells grown in DMEM
without antibiotics. Cells were transfected 48 hr before each experiment.
RIPA Extraction
Cells were washed with PBS and incubated on ice for 5 min in RIPA buffer plus
1 mg/mL each of leupeptin, aprotinin, and pepstatin. Tubes were briefly soni-
cated and then centrifuged at 21,000 3 g for 10 min at 4C. Supernatants
were quantified by Bradford assay before LDS (lithium dodecyl sulfate) sample
buffer (NP0007, Invitrogen) and DTT were added to a final concentration of 13,
and 50 mM, respectively. Samples were heated to 70C for 5 min, centrifuged
at maximum speed for 5 min, and loaded onto SDS-PAGE gels.
Drug and Replication Stress Treatments
All experiments with HeLa cells used drugs at the following final concentra-
tions: XL413 (10 mM), PHA-767491 (10 mM), caffeine (5 mM), CHIR-124
(5 mM), tautomycetin (225 nM), hydroxyurea (5 mM), aphidicolin (1 mg/mL),
methyl methanesulfonate (0.02%), camptothecin (5 mM), and etoposide
(5 mM). UV damage was induced by removing media from the tissue culture
plate and irradiating (45 J/m2). Media were added back, and cells were incu-
bated for 2 hr before harvesting.
DNA Fiber Analysis
Cells were treated with 20 mM chlorodeoxyuridine (CldU) and 100 mM
iododeoxyuridine (IdU) for the indicated times, harvested, counted, and resus-
pended with an equal number of unlabeled cells at a concentration of 1 3 106
total cells permilliliter.2,000 cells (2-mL cell suspension) were pipetted onto a
glass slide and incubated in a humid chamber for 4 min. Cells were lysed with
8 mL digestion buffer (200 mM Tris [pH 7.4], 50 mM EDTA, 0.5% SDS), incu-
bated for 7 min in a humid chamber, and then tilted 15 to allow the DNA to
spread down the length of the slide. CldU was detected with BioRad
OBT0030CX antibody, and IdU was detected with BD 357580 antibody. Im-
ages were acquired using a charge-coupled device (CCD) camera connected
to an Olympus IX70 deltavision deconvolution microscope under a 403 oil
immersion objective. >25 fields were captured for each experiment, and 100
fibers per condition weremeasured using Volocity 3D Image Analysis software
(PerkinElmer).
Microscopy
Cells were seeded into 10-cm dishes containing glass coverslips. Under indi-
cated conditions, coverslips were removed from the dish, washed with PBS,
fixed with 4% formaldehyde, permeabilized with 0.2% Triton X-100, washed,
and blocked in 0.5% fish gelatin in PBS containing 0.1% Tween 20. EdU was
detected using the Click-iT EdU reaction (Thermo Fisher Scientific), and cov-
erslips were washed, incubated with DAPI (D9542; Sigma), andmounted using
Vectashield (H-1000; Vector Laboratories). Imageswere acquired using a CCD
camera connected to an Olympus IX70 deltavision deconvolution microscope
under a 1003 oil immersion objective. Imageswere analyzed using Volocity 3D
Image Analysis software (PerkinElmer). Briefly, each nucleus was outlined as
the region of interest utilizing the DAPI signal, and this was used to determine
total nuclear EdU. After setting the nuclear background intensity, the number
of nuclear EdU foci and intensity of EdU signal were obtained by running
the following program: (1) find objects using intensity; (2) clip to region of
interests (ROIs); (3) remove noise from objects (fine filter); (4) separate touching
objects (object size guide, 0.02 mm3); (5) exclude objects by size (exclude
objects < 0.015 mm3).
Recombinant Proteins, Reagents, and Antibodies
Full-length p27kip1 was expressed from pGEX-p27kip1 plasmid (a gift of J.
Walter, Harvard Medical School) as described previously (Poh et al., 2014).
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Chemicals were acquired as follows: PHA-767491, from the Division of Signal
Transduction Therapy, University of Dundee; XL413, Axon Medchem (#2268)
and a gift from Cancer Research Technology; tautomycetin, Tocris (#2305);
CHIR-124, Axon Medchem (Axon 1636); and KU55933, Axon Medchem
(Axon 1367). Antibodies against Xenopus proteins were as described:
Mcm3, Mcm4, and Mcm7 (Prokhorova and Blow, 2000); Cdc45 and Psf2
(Gambus et al., 2011). Xenopus Rif1 antibody was raised in rabbit against
the C-terminal 100 amino acids expressed in bacteria; the antisera were
purified over protein A beads (see Figure S2). Antibodies against human
Mcm4 (sc-22779), Mcm5 (sc-136336), PCNA (sc-56), PP1a (sc-6104), and
PP1g (sc-6108) were from Santa Cruz Biotechnology. Anti-Mcm2 was from
BD Biosciences (#610701). Lamin B (ab16048), Mcm2 (phospho S40)
(ab133243), Mcm2 (phospho S53) (ab109133), Rif1 (ab140464 and
ab70254), and Cdc7 (ab1053) were from Abcam. Tubulin (T6199) was from
Sigma-Aldrich. Antibodies raised against human Mcm2 and phospho-Mcm2
recognize the cognate proteins in Xenopus (Figures S2B–S2D; note that the
Xenopus orthologs of human Mcm2 Ser40 and Ser53 are Ser25 and Ser38,
respectively).
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